Latest Interviews
"A combination of unprecedented shipping costs coupled with steeply rising raw material costs and challenges around securing raw materials has had the entire additives industry struggling to pass on their costs."
59370
“One of our guiding principles is to be simultaneously global and local (glocal), which gives our clients a double advantage: A diversified portfolio and geographically optimum supplies from the cheapest markets,and an intimate understanding of local markets so as to gain the best arbitrage.”
59360
"The focus of our integrated Translational Pharmaceutics programs is to provide the customer with a development platform capable of responding in real-time to emerging development data and maintain an overall timeline to proof of concept."
59358
"Our fixed-price, fastest DNA-to-IND program is packaged in a standardized platform to allow clients to bring a new antibody molecule to IND filing in a rapid amount of time."
59356
"We spent the past two years developing closer connections to our clients, vendors and clinical partners on a global scale."
59354
"Today, we have 96 customers in our network, ranging from very small virtual pharma companies to large, global pharma organizations."